Noscapine

CAS No. 128-62-1

Noscapine( (SR)-Noscapine | Narcotine )

Catalog No. M21130 CAS No. 128-62-1

Noscapine is a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Noscapine
  • Note
    Research use only, not for human use.
  • Brief Description
    Noscapine is a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
  • Description
    Noscapine is a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (SR)-Noscapine | Narcotine
  • Pathway
    Autophagy
  • Target
    Sigma receptor
  • Recptor
    σ-receptor
  • Research Area
    cancer
  • Indication
    Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia

Chemical Information

  • CAS Number
    128-62-1
  • Formula Weight
    413.42
  • Molecular Formula
    C22H23NO7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (72.57 mM)
  • SMILES
    COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C
  • Chemical Name
    (S)-67-dimethoxy-3-((R)-4-methoxy-6-methyl-5678-tetrahydro-[13]dioxolo[45-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Altinoz MA Topcu G Hacimuftuoglu Aet al.Noscapine a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.Neurochem Res. 2019 Aug;44(8):1796-1806.
molnova catalog
related products
  • MIN-101

    MIN-101 (Roluperidone, CYR-101, MT-210) is a higly potent 5-HT2A and sigma 2 receptor antagonist.

  • Sigma-1 receptor ant...

    Sigma-1 receptor antagonist 3 is a more potent and selective antagonist of Sigma-1 (σ1) receptor (Ki = 1.14 nM) than σ2 receptor(Ki = 1239 nM).

  • Glycerol phenylbutyr...

    Glycerol phenylbutyrate (GPB) is a new generation ammonia scavenger drug and it also is a sigma-2 (σ2) receptor ligand (pKi: 8.02).Glycerol phenylbutyrate may have therapeutic potential in additional conditions such as chronic hepatic encephalopathy or other inherited metabolic disorders. Glycerol phenylbutyrate also has the potential for the treatment of hyperammonemia.